Cargando…

Isolated Asymptomatic Fetal Intracardiac Mass: A Case of Rhabdomyoma

INTRODUCTION: Fetal cardiac rhabdomyoma is one of the rare benign cardiac masses which is commonly associated with the tuberous sclerosis complex (TSC). Though mostly fetal cardiac rhabdomyoma is asymptomatic it may lead to life-threatening conditions like outflow obstruction, arrhythmias, hydrops f...

Descripción completa

Detalles Bibliográficos
Autores principales: Eticha, Tadesse Gure, Ararso, Roba, Sultan, Semir, Terefe, Kiros, Berhe, Solomon Wubneh, Tsega, Temesgen, Abebe, Yeshiwas, Baye, Chernet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985386/
https://www.ncbi.nlm.nih.gov/pubmed/36880053
http://dx.doi.org/10.2147/IMCRJ.S402663
Descripción
Sumario:INTRODUCTION: Fetal cardiac rhabdomyoma is one of the rare benign cardiac masses which is commonly associated with the tuberous sclerosis complex (TSC). Though mostly fetal cardiac rhabdomyoma is asymptomatic it may lead to life-threatening conditions like outflow obstruction, arrhythmias, hydrops fetalis, or sudden fetal death. CASE REPORT: We are reporting an isolated, asymptomatic fetal intra-cardiac mass (rhabdomyoma) that was discovered at 32 weeks of gestation and was followed as an outpatient until 39 weeks plus one day, at which point a cesarean section was performed. After delivery, the child underwent evaluations at the 1(st) day, 7(th) day, 30(th) day, 7(th) month, and 12(th) month of age. Following a checkup, the child’s anthropometric and neurobehavioral growth were both healthy. Except for the tumor, which was neither growing nor shrinking in size, none of the clinical diagnostic criteria for tuberous sclerosis complex were met for this child up to the age of one year. CONCLUSION: The most common primary benign fetal cardiac tumor is cardiac rhabdomyoma, which is usually associated with tuberous sclerosis. In developing nations where it is challenging to obtain MRIs and genetic studies, and in a similar patient like ours with no other features of tuberous sclerosis, the child needs to be followed in the future, bearing in mind that tuberous sclerosis manifestations will continue to develop over a patient’s lifetime.